N·Acetyl-leukotriene E 4 (N-Ac-LTE 4 ) is a recently discovered metabolite of the cysteinylleukotrienes (L T).
conscious rat (0.1-30 JLg/kg) and blood flow (BF) in the R, M, and HQ regionswas continuously recorded, as was the systemic BP and heart rate. N·Ac-L TE 4 (n = 6) produced only a moderate pressor response (5-15 mmHg). However, MBF was reduced in a dose-dependent manner (up to -50% at 30 s.t&/kg), along with an increase in the MVR: 300% (30 s.tg/kg). N-Ac·L TE 4 bad no effect at all on the renal or HQ circulation in the dose range studied (FIGURE 1 ). Comparison of the duration of the effect of N·Ac·LTE 4 on MBF to that of LTD 4 revealed a more prolonged effect of N-Ac-LTE 4 (FIGURE 2).
The data presented in this report clearly show that N-Ac-L TE 4 is a biologically active metabolite of LT. N-Ac-LTE 4 bad a preferential effect on the mesenteric circulation with virtually no effect on the R and HQ circulation. In this regard, N-Ac-LTE 4 is more specific than LTD 4 or LTE 4 , which produce significant renal and HQ vasoconstriction in comparable doses 4 in this same model. The effects of N-Ac-LTE 4 in the rat are substantially different from those described in the pig. 3 The significant vasoconstrictor activity of N-Ac-L TE 4 in the rat, taken tagether with this LT being the primary bile metabolite, and the possible enterohepatic recycling of LT suggest that N-Ac-LTE 4 might play an important role in systemic effects of L T in this species. Furthermore, the possible role of N·Ac-L TE 4 in mediation of some of the overall LT effects also presents the need to evaluate LT antagonists against N-Ac-LTE 4 because the failure of some LT antagonists to effectively block N-Ac-LTE/ might underlie their limited capacity to prevent or reverse L T -mediated pathological processes.
